BioCentury
ARTICLE | Company News

Kos and DuPont submit NDA

September 26, 2000 7:00 AM UTC

KOSP and DD subsidiary DuPont Pharmaceuticals submitted an NDA to the FDA for a product that combines KOSP's Niaspan extended release niacin with generic lovastatin to improve total lipid levels. In M...